RPRX · Royalty Pharma plc · Investor Relations

$57.16 -0.47 (-0.82%) At close · Oct 2

Russell 1000 member Rebalance outlook locked

Market Cap

$33.47B

575.00M

Volume · Oct 2 2.23M Avg daily vol (3M) 2.91M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-09-23	Royalty Pharma at the BofA Global Research Global Healthcare Conference	Conference
2026-09-14	Royalty Pharma at the Morgan Stanley 24th Annual Global Healthcare Conference	Conference
2026-08-05	Royalty Pharma Q2 2026 Financial Results Call	Earnings call
2026-06-09	Royalty Pharma at the Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-05-19	Royalty Pharma at the RBC Capital Markets 2026 Global Healthcare Conference	Conference
2026-05-13	Royalty Pharma at the BofA Securities 2026 Health Care Conference	Conference
2026-05-06	Royalty Pharma Q1 2026 Financial Results Call	Earnings call
2026-03-03	Royalty Pharma at TD Cowen’s 46th Annual Health Care Conference	Conference
2026-02-11	Royalty Pharma Q4 2025 Financial Results Call	Earnings call
2026-01-13	Royalty Pharma at the 44th Annual J.P. Morgan Healthcare Conference	Conference
2025-12-03	Royalty Pharma at the 8th Annual Evercore Healthcare Conference	Conference
2025-12-02	Royalty Pharma at the Citi 2025 Global Healthcare Conference	Conference
2025-11-05	Royalty Pharma Q3 2025 Financial Results Call	Earnings call

Source: https://www.royaltypharma.com/investors/

Key facts CIK 1802768 CUSIP G7709Q104 13F (30d) 12 filings 12 filers Visit website Investor relations